Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
Francesco Perri1, Francesco Longo2, Franco Ionna2, Francesco Caponigro11Head and Neck Medical Oncology Unit, 2Head and Neck Surgery Unit, National Tumor Institute of Naples, Naples, ItalyAbstract: Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor. The role...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-08-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/recent-results-of-cetuximab-use-in-the-treatment-of-squamous-cell-carc-a3492 |